The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Continuous Blood Glucose Monitoring Systems-Global Market Insights and Sales Trends 2025
Synopsis
A CGM system provides continuous insight into glucose levels throughout the day and night. The device displays information about glucose direction and rate of change providing users additional information to help with their diabetes management. Studies have shown that CGM systems may help reduce your A1C and reduce your risk for hypoglycemia, whether you are on insulin injections or pump Therapy.
The global Continuous Blood Glucose Monitoring Systems market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Continuous Blood Glucose Monitoring Systems in various end use industries. The expanding demands from the Self/Home Care and Hospital & Clinics, are propelling Continuous Blood Glucose Monitoring Systems market. Self-Monitoring Blood Glucose Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Continuous Glucose Monitoring Systems segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Continuous Blood Glucose Monitoring Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Continuous Blood Glucose Monitoring Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Continuous Blood Glucose Monitoring Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Continuous Blood Glucose Monitoring Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Continuous Blood Glucose Monitoring Systems covered in this report include Abbott Laboratories, F. Hoffmann-La Roche, Lifescan, Ascensia Diabetes Care, Dexcom, Medtronic, Ypsomed, B. Braun Melsungen and Nipro, etc.
The global Continuous Blood Glucose Monitoring Systems market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
F. Hoffmann-La Roche
Lifescan
Ascensia Diabetes Care
Dexcom
Medtronic
Ypsomed
B. Braun Melsungen
Nipro
Sanofi
Arkray
Prodigy Diabetes Care
Acon Laboratories
Nova Biomedical
Global Continuous Blood Glucose Monitoring Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Continuous Blood Glucose Monitoring Systems market, Segment by Type:
Self-Monitoring Blood Glucose Systems
Continuous Glucose Monitoring Systems
Global Continuous Blood Glucose Monitoring Systems market, by Application
Self/Home Care
Hospital & Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Continuous Blood Glucose Monitoring Systems companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A CGM system provides continuous insight into glucose levels throughout the day and night. The device displays information about glucose direction and rate of change providing users additional information to help with their diabetes management. Studies have shown that CGM systems may help reduce your A1C and reduce your risk for hypoglycemia, whether you are on insulin injections or pump Therapy.
The global Continuous Blood Glucose Monitoring Systems market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Continuous Blood Glucose Monitoring Systems in various end use industries. The expanding demands from the Self/Home Care and Hospital & Clinics, are propelling Continuous Blood Glucose Monitoring Systems market. Self-Monitoring Blood Glucose Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Continuous Glucose Monitoring Systems segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Continuous Blood Glucose Monitoring Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Continuous Blood Glucose Monitoring Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Continuous Blood Glucose Monitoring Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Continuous Blood Glucose Monitoring Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Continuous Blood Glucose Monitoring Systems covered in this report include Abbott Laboratories, F. Hoffmann-La Roche, Lifescan, Ascensia Diabetes Care, Dexcom, Medtronic, Ypsomed, B. Braun Melsungen and Nipro, etc.
The global Continuous Blood Glucose Monitoring Systems market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
F. Hoffmann-La Roche
Lifescan
Ascensia Diabetes Care
Dexcom
Medtronic
Ypsomed
B. Braun Melsungen
Nipro
Sanofi
Arkray
Prodigy Diabetes Care
Acon Laboratories
Nova Biomedical
Global Continuous Blood Glucose Monitoring Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Continuous Blood Glucose Monitoring Systems market, Segment by Type:
Self-Monitoring Blood Glucose Systems
Continuous Glucose Monitoring Systems
Global Continuous Blood Glucose Monitoring Systems market, by Application
Self/Home Care
Hospital & Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Continuous Blood Glucose Monitoring Systems companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Continuous Blood Glucose Monitoring Systems
1.1 Continuous Blood Glucose Monitoring Systems Market Overview
1.1.1 Continuous Blood Glucose Monitoring Systems Product Scope
1.1.2 Continuous Blood Glucose Monitoring Systems Market Status and Outlook
1.2 Global Continuous Blood Glucose Monitoring Systems Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Continuous Blood Glucose Monitoring Systems Market Size by Region (2018-2029)
1.4 Global Continuous Blood Glucose Monitoring Systems Historic Market Size by Region (2018-2023)
1.5 Global Continuous Blood Glucose Monitoring Systems Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Continuous Blood Glucose Monitoring Systems Market Size (2018-2029)
1.6.1 North America Continuous Blood Glucose Monitoring Systems Market Size (2018-2029)
1.6.2 Europe Continuous Blood Glucose Monitoring Systems Market Size (2018-2029)
1.6.3 Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size (2018-2029)
1.6.4 Latin America Continuous Blood Glucose Monitoring Systems Market Size (2018-2029)
1.6.5 Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size (2018-2029)
2 Continuous Blood Glucose Monitoring Systems Market by Type
2.1 Introduction
2.1.1 Self-Monitoring Blood Glucose Systems
2.1.2 Continuous Glucose Monitoring Systems
2.2 Global Continuous Blood Glucose Monitoring Systems Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Continuous Blood Glucose Monitoring Systems Historic Market Size by Type (2018-2023)
2.2.2 Global Continuous Blood Glucose Monitoring Systems Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Continuous Blood Glucose Monitoring Systems Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Continuous Blood Glucose Monitoring Systems Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Continuous Blood Glucose Monitoring Systems Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Continuous Blood Glucose Monitoring Systems Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Continuous Blood Glucose Monitoring Systems Revenue Breakdown by Type (2018-2029)
3 Continuous Blood Glucose Monitoring Systems Market Overview by Application
3.1 Introduction
3.1.1 Self/Home Care
3.1.2 Hospital & Clinics
3.2 Global Continuous Blood Glucose Monitoring Systems Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Continuous Blood Glucose Monitoring Systems Historic Market Size by Application (2018-2023)
3.2.2 Global Continuous Blood Glucose Monitoring Systems Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Continuous Blood Glucose Monitoring Systems Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Continuous Blood Glucose Monitoring Systems Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Continuous Blood Glucose Monitoring Systems Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Continuous Blood Glucose Monitoring Systems Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Continuous Blood Glucose Monitoring Systems Revenue Breakdown by Application (2018-2029)
4 Continuous Blood Glucose Monitoring Systems Competition Analysis by Players
4.1 Global Continuous Blood Glucose Monitoring Systems Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Continuous Blood Glucose Monitoring Systems as of 2022)
4.3 Date of Key Players Enter into Continuous Blood Glucose Monitoring Systems Market
4.4 Global Top Players Continuous Blood Glucose Monitoring Systems Headquarters and Area Served
4.5 Key Players Continuous Blood Glucose Monitoring Systems Product Solution and Service
4.6 Competitive Status
4.6.1 Continuous Blood Glucose Monitoring Systems Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Continuous Blood Glucose Monitoring Systems Products, Services and Solutions
5.1.4 Abbott Laboratories Continuous Blood Glucose Monitoring Systems Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 F. Hoffmann-La Roche
5.2.1 F. Hoffmann-La Roche Profile
5.2.2 F. Hoffmann-La Roche Main Business
5.2.3 F. Hoffmann-La Roche Continuous Blood Glucose Monitoring Systems Products, Services and Solutions
5.2.4 F. Hoffmann-La Roche Continuous Blood Glucose Monitoring Systems Revenue (US$ Million) & (2018-2023)
5.2.5 F. Hoffmann-La Roche Recent Developments
5.3 Lifescan
5.3.1 Lifescan Profile
5.3.2 Lifescan Main Business
5.3.3 Lifescan Continuous Blood Glucose Monitoring Systems Products, Services and Solutions
5.3.4 Lifescan Continuous Blood Glucose Monitoring Systems Revenue (US$ Million) & (2018-2023)
5.3.5 Ascensia Diabetes Care Recent Developments
5.4 Ascensia Diabetes Care
5.4.1 Ascensia Diabetes Care Profile
5.4.2 Ascensia Diabetes Care Main Business
5.4.3 Ascensia Diabetes Care Continuous Blood Glucose Monitoring Systems Products, Services and Solutions
5.4.4 Ascensia Diabetes Care Continuous Blood Glucose Monitoring Systems Revenue (US$ Million) & (2018-2023)
5.4.5 Ascensia Diabetes Care Recent Developments
5.5 Dexcom
5.5.1 Dexcom Profile
5.5.2 Dexcom Main Business
5.5.3 Dexcom Continuous Blood Glucose Monitoring Systems Products, Services and Solutions
5.5.4 Dexcom Continuous Blood Glucose Monitoring Systems Revenue (US$ Million) & (2018-2023)
5.5.5 Dexcom Recent Developments
5.6 Medtronic
5.6.1 Medtronic Profile
5.6.2 Medtronic Main Business
5.6.3 Medtronic Continuous Blood Glucose Monitoring Systems Products, Services and Solutions
5.6.4 Medtronic Continuous Blood Glucose Monitoring Systems Revenue (US$ Million) & (2018-2023)
5.6.5 Medtronic Recent Developments
5.7 Ypsomed
5.7.1 Ypsomed Profile
5.7.2 Ypsomed Main Business
5.7.3 Ypsomed Continuous Blood Glucose Monitoring Systems Products, Services and Solutions
5.7.4 Ypsomed Continuous Blood Glucose Monitoring Systems Revenue (US$ Million) & (2018-2023)
5.7.5 Ypsomed Recent Developments
5.8 B. Braun Melsungen
5.8.1 B. Braun Melsungen Profile
5.8.2 B. Braun Melsungen Main Business
5.8.3 B. Braun Melsungen Continuous Blood Glucose Monitoring Systems Products, Services and Solutions
5.8.4 B. Braun Melsungen Continuous Blood Glucose Monitoring Systems Revenue (US$ Million) & (2018-2023)
5.8.5 B. Braun Melsungen Recent Developments
5.9 Nipro
5.9.1 Nipro Profile
5.9.2 Nipro Main Business
5.9.3 Nipro Continuous Blood Glucose Monitoring Systems Products, Services and Solutions
5.9.4 Nipro Continuous Blood Glucose Monitoring Systems Revenue (US$ Million) & (2018-2023)
5.9.5 Nipro Recent Developments
5.10 Sanofi
5.10.1 Sanofi Profile
5.10.2 Sanofi Main Business
5.10.3 Sanofi Continuous Blood Glucose Monitoring Systems Products, Services and Solutions
5.10.4 Sanofi Continuous Blood Glucose Monitoring Systems Revenue (US$ Million) & (2018-2023)
5.10.5 Sanofi Recent Developments
5.11 Arkray
5.11.1 Arkray Profile
5.11.2 Arkray Main Business
5.11.3 Arkray Continuous Blood Glucose Monitoring Systems Products, Services and Solutions
5.11.4 Arkray Continuous Blood Glucose Monitoring Systems Revenue (US$ Million) & (2018-2023)
5.11.5 Arkray Recent Developments
5.12 Prodigy Diabetes Care
5.12.1 Prodigy Diabetes Care Profile
5.12.2 Prodigy Diabetes Care Main Business
5.12.3 Prodigy Diabetes Care Continuous Blood Glucose Monitoring Systems Products, Services and Solutions
5.12.4 Prodigy Diabetes Care Continuous Blood Glucose Monitoring Systems Revenue (US$ Million) & (2018-2023)
5.12.5 Prodigy Diabetes Care Recent Developments
5.13 Acon Laboratories
5.13.1 Acon Laboratories Profile
5.13.2 Acon Laboratories Main Business
5.13.3 Acon Laboratories Continuous Blood Glucose Monitoring Systems Products, Services and Solutions
5.13.4 Acon Laboratories Continuous Blood Glucose Monitoring Systems Revenue (US$ Million) & (2018-2023)
5.13.5 Acon Laboratories Recent Developments
5.14 Nova Biomedical
5.14.1 Nova Biomedical Profile
5.14.2 Nova Biomedical Main Business
5.14.3 Nova Biomedical Continuous Blood Glucose Monitoring Systems Products, Services and Solutions
5.14.4 Nova Biomedical Continuous Blood Glucose Monitoring Systems Revenue (US$ Million) & (2018-2023)
5.14.5 Nova Biomedical Recent Developments
6 North America
6.1 North America Continuous Blood Glucose Monitoring Systems Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Continuous Blood Glucose Monitoring Systems Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Continuous Blood Glucose Monitoring Systems Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Continuous Blood Glucose Monitoring Systems Market Dynamics
11.1 Continuous Blood Glucose Monitoring Systems Industry Trends
11.2 Continuous Blood Glucose Monitoring Systems Market Drivers
11.3 Continuous Blood Glucose Monitoring Systems Market Challenges
11.4 Continuous Blood Glucose Monitoring Systems Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
